Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An asphyxiating thoracic dystrophy that has material basis in homozygous or compound heterozygous mutation in the WDR34 gene on chromosome 9q34.
Features include sometimes findings: Nephrocalcinosis, Polyhydramnios, Delayed speech and language development, and Postaxial polydactyly and others. 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 2 | Difficulty breathing (respiratory insufficiency), Recurrent respiratory infections |
DYNC2I2 encodes dynein 2 intermediate chain 2 (536 aa). Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system. Highest expression in Testis (121.8 TPM) and Thyroid (101.6 TPM).
Short-rib thoracic dysplasia 11 with or without polydactyly is caused by mutations in the DYNC2I2 gene on chromosome 9.
DYNC2I2 is classified as a druggable target with score 0.0.
Genetic testing for DYNC2I2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for short-rib thoracic dysplasia 11 with or without polydactyly has been reported in the published literature.
No clinical trials have been registered for short-rib thoracic dysplasia 11 with or without polydactyly.
200 publications have been identified in PubMed for short-rib thoracic dysplasia 11 with or without polydactyly. Kisho has analyzed 18 by research type. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (28%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 44% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 3:32 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Kidneys and urinary system
1 |
Nephrocalcinosis |
Bones and joints | 1 | Short long bone |
Brain and nerves | 1 | Delayed speech and language development |
Blood and immune system | 1 | Recurrent respiratory infections |
Research summaries |
5 |
28% |
Disease patterns and progression | 3 | 17% |
Testing and diagnosis research | 1 | 6% |
New treatment approaches | 1 | 6% |
Wang Z (2026). [PMID: 41503593](https://pubmed.ncbi.nlm.nih.gov/41503593/). *Clin Case Rep*. [Case Report / Case Series]
Ak B (2025). [PMID: 40339774](https://pubmed.ncbi.nlm.nih.gov/40339774/). *Bone*. [Case Report / Case Series]
Nitoiu A (2025). [PMID: 40273360](https://pubmed.ncbi.nlm.nih.gov/40273360/). *Hum Mol Genet*. [Case Report / Case Series]
Hakeem A (2025). [PMID: 39781470](https://pubmed.ncbi.nlm.nih.gov/39781470/). *Int J Biol Sci*. [Review / Meta-Analysis]
Vazquez N (2025). [PMID: 40593758](https://pubmed.ncbi.nlm.nih.gov/40593758/). *Nat Commun*. [Epidemiology / Natural History]
Syngelaki A (2025). [PMID: 40131231](https://pubmed.ncbi.nlm.nih.gov/40131231/). *Ultrasound Obstet Gynecol*. [Diagnostic / Biomarker]
Dollfus H (2024). [PMID: 39085583](https://pubmed.ncbi.nlm.nih.gov/39085583/). *Eur J Hum Genet*. [Review / Meta-Analysis]
Kanitkar S (2024). [PMID: 39542505](https://pubmed.ncbi.nlm.nih.gov/39542505/). *BMJ Case Rep*. [Case Report / Case Series]
Yu QX (2024). [PMID: 38840299](https://pubmed.ncbi.nlm.nih.gov/38840299/). *Prenat Diagn*. [Case Report / Case Series]
Junior JHMF (2024). [PMID: 38459147](https://pubmed.ncbi.nlm.nih.gov/38459147/). *Childs Nerv Syst*. [Review / Meta-Analysis]